Detection of Electrocardiographic Brugada Patterns Using High Precordial Leads

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05116488
Collaborator
(none)
300
24

Study Details

Study Description

Brief Summary

Detection of prevalence of Brugada patterns in our locality in asymptomatic patients , by standard 12 lead ECG level and high precordial ECG level, measuring how much the high precordial leads is more sensitive in Brugada patterns detection than standard level 12 lead ECG in our upper Egyptian population.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: ECG(electrocardigraph)

Detailed Description

Detection of prevalence of Brugada patterns in our locality in asymptomatic patients , by standard 12 lead ECG level and high precordial ECG level, measuring how much the high precordial leads is more sensitive in Brugada patterns detection than standard level 12 lead ECG in our upper Egyptian population.

The study will include patients fulfilling our criteria presenting to cardiology outpatient clinic and emergency room of Assiut University hospitals.

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Detection of Electrocardiographic Brugada Patterns Using High Precordial Leads Positioning Among Asymptomatic Upper Egyptian Population
Anticipated Study Start Date :
Dec 31, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. Detection of electrocardiographic Brugada patterns using high precordial leads positioning among asymptomatic upper Egyptian population [up to 4 hours for each case to make sure of meeting eligibility criteria]

    Detection of prevalence of Brugada patterns in our locality in asymptomatic patients , by standard 12 lead ECG level and high precordial ECG level, measuring how much the high precordial leads is more sensitive in Brugada patterns detection than standard level 12 lead ECG in our upper Egyptian population.

Secondary Outcome Measures

  1. Follow up of positive cases [six months after diagnosis of Brugada pattern for each case]

    The positive cases will be educated regarding their condition, asked about their history of syncope and family history of sudden cardiac death and will be educated about avoiding and rapid management of fever and electrolyte disturbances and educated about the list of drugs to be avoided. The positive cases will be followed up for 6 months both clinically and by Holter at 1st, and 6th month for detection of subclinical ventricular arrhythmias.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  1. patients with IHD,HTN,DM with no organic heart disease by ECHO.

  2. healthy persons with normal structure heart by ECHO.

Exclusion Criteria:
  1. Acute coronary syndrome.

  2. cardiomyopathy.

  3. severe valvular heart disease.

  4. HTN heart disease with LVH.

  5. Malignancy.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Study Director: Salah Eldin Sayed Atta, Professor, Assiut University
  • Study Director: Mahmoud Abdelsabour, Lecturer, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Alaa Rashad Ali, Doctor, Assiut University
ClinicalTrials.gov Identifier:
NCT05116488
Other Study ID Numbers:
  • ECG Brugada patterns
First Posted:
Nov 11, 2021
Last Update Posted:
Nov 17, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2021